The trial followed 54 healthy adults over six months, dividing them into a placebo group, a low-dose group (250 mg/day), and a high-dose group (1000 mg/day), meticulously tracking glutathione levels across multiple cellular compartments, as detailed in the published clinical trial
The jury is still out on the long-term effects and results of GLP-1s, but early signs indicate stabilization for diabetic members with respect to cost and clinical outcomes
That seemed to be the only thing that the mainstream press was interested in doing was praising GLP-1s and throwing this incredibly important historical movement under the bus
Research-Backed Insights on GLP-1 Agonists and Weight Loss Studies have consistently shown that GLP-1 analogs can result in significant weight loss, with participants losing an average of 5-15% of their body weight over 6-12 months
Prevention: Set a recurring weekly calendar reminder for your injection day